Niagen Bioscience (NAGE)

• Market cap: $277M
• 1 day: -0.57%
• 5 days: 0%
• 1 month: -4.92%
• 3 months: -26.11%
• 6 months: -48.14%
• Year to date: -44.32%
• 1 year: -74.49%
• 5 years: -60.81%
• 10 years: 14.47%
• Sector: Healthcare
• Industry: Biotechnology

About: Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Employees: 117